ClinVar Miner

Submissions for variant NM_005502.4(ABCA1):c.3584G>A (p.Arg1195Gln)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV002976388 SCV003290870 likely benign not provided 2023-09-18 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV003317635 SCV004021016 likely benign not specified 2023-06-19 criteria provided, single submitter clinical testing Variant summary: ABCA1 c.3584G>A (p.Arg1195Gln) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8.4e-05 in 251482 control chromosomes in GnomAD. The observed variant frequency is approximately 6.7 fold of the estimated maximal expected allele frequency for a pathogenic variant in ABCA1 causing Early Onset Coronary Artery Disease phenotype (1.3e-05), strongly suggesting that the variant is benign. c.3584G>A has been reported in the literature in individuals affected with features of Early Onset Coronary Artery Disease without strong evidence for causality (example, Dron_2020). These report(s) do not provide unequivocal conclusions about association of the variant with Early Onset Coronary Artery Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 32041611). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as likely benign.
New York Genome Center RCV003336787 SCV004046581 uncertain significance Hypoalphalipoproteinemia, primary, 1; Tangier disease 2022-10-26 criteria provided, single submitter clinical testing
GeneDx RCV002976388 SCV005332328 uncertain significance not provided 2023-11-08 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 32041611)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.